Back to top
more

IDEXX Laboratories (IDXX)

(Delayed Data from NSDQ)

$499.30 USD

499.30
529,831

+10.06 (2.06%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $499.30 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (94 out of 252)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for IDXX

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for IDEXX Laboratories, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 454 113 144 384 90
Receivables 457 401 368 331 269
Notes Receivable 0 0 0 0 0
Inventories 380 368 269 210 195
Other Current Assets 204 220 174 138 125
Total Current Assets 1,495 1,101 956 1,063 680
Net Property & Equipment 702 649 588 555 534
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 450 459 458 296 298
Deposits & Other Assets 497 418 330 290 240
Total Assets 3,260 2,747 2,437 2,295 1,832
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 250 579 74 0 289
Accounts Payable 111 110 116 75 72
Current Portion Long-Term Debt 75 75 75 50 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 479 434 459 416 323
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 37 38 40 43 41
Total Current Liabilities 952 1,236 764 583 725
Mortgages 0 0 0 0 0
Deferred Taxes/Income 36 39 50 58 82
Convertible Debt 0 0 0 0 0
Long-Term Debt 623 694 775 858 699
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 66 68 71 86 81
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 1,775 2,138 1,747 1,662 1,655
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 11 11 11 11 11
Capital Surplus 1,570 1,463 1,377 1,295 1,214
Retained Earnings 4,445 3,600 2,920 2,176 1,596
Other Equity -66 -73 -48 -48 -41
Treasury Stock 4,475 4,392 3,571 2,800 2,601
Total Shareholder's Equity 1,485 609 690 633 178
Total Liabilities & Shareholder's Equity 3,260 2,747 2,437 2,295 1,832
Total Common Equity 1,485 609 690 633 178
Shares Outstanding 83.00 82.80 84.70 85.30 85.70
Book Value Per Share 17.89 7.35 8.15 7.42 2.08

Fiscal Year End for IDEXX Laboratories, Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 454 332 133 111
Receivables NA 457 453 462 446
Notes Receivable NA 0 0 0 0
Inventories NA 380 394 395 391
Other Current Assets NA 204 206 189 201
Total Current Assets NA 1,495 1,384 1,179 1,149
Net Property & Equipment NA 702 687 683 665
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 450 449 455 457
Deposits & Other Assets NA 497 448 439 421
Total Assets NA 3,260 3,086 2,871 2,808
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 250 250 264 432
Accounts Payable NA 111 113 108 118
Current Portion Long-Term Debt NA 75 150 75 75
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 479 420 399 404
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 37 37 38 38
Total Current Liabilities NA 952 970 884 1,066
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 36 38 35 36
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 623 619 697 696
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 60 64 71
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 1,775 1,789 1,777 1,967
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 11 11 11 11
Capital Surplus NA 1,570 1,543 1,515 1,490
Retained Earnings NA 4,445 4,250 4,038 3,814
Other Equity NA -66 -69 -68 -71
Treasury Stock NA 4,475 4,437 4,402 4,402
Total Shareholder's Equity NA 1,485 1,297 1,094 841
Total Liabilities & Shareholder's Equity NA 3,260 3,086 2,871 2,808
Total Common Equity 0 1,485 1,297 1,094 841
Shares Outstanding 83.00 83.00 83.00 83.00 83.00
Book Value Per Share 0.00 17.89 15.63 13.18 10.13